GLP-1 (Glucagon-like peptide-1) is a receptor agonist designed to help regulate hunger, slow digestion, and support steady, long-term weight managementall delivered through a convenient, physician-guided weekly injection
Dani SS, Makwana B, Khadke S, Kumar A, Jhund P, Nasir K, Sattar N, Al-Kindi S, Fonarow G, Butler J, Bhatt DL, Kosiborod MN, Nohria A, Ganatra S (2025) An observational study of cardiovascular outcomes of tirzepatide vs glucagon-like peptide-1 receptor agonists
Phase 2 trials, completed in 2023, demonstrated remarkable efficacy across multiple dose levels
Both publish their own figures and revise them over time, so compare each brand's current pricing page directly before deciding which model suits your budget
Retatrutide Phase 2 Study NCT05934110: A Study of Retatrutide in Participants With Obesity
GLP-1 medications perform similarly or sometimes better